Cargando…
Identification of human adenovirus replication inhibitors from a library of small molecules targeting cellular epigenetic regulators
Human adenovirus (HAdV) can cause severe disease in certain at-risk populations such as newborns, young children, the elderly and individuals with a compromised immune system. Unfortunately, no FDA-approved antiviraldrug is currently available for the treatment of HAdV infections. Within the nucleus...
Autores principales: | Saha, Bratati, Parks, Robin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382930/ https://www.ncbi.nlm.nih.gov/pubmed/33032802 http://dx.doi.org/10.1016/j.virol.2020.07.007 |
Ejemplares similares
-
Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells
por: Saha, Bratati, et al.
Publicado: (2017) -
Recent Advances in Novel Antiviral Therapies against Human Adenovirus
por: Saha, Bratati, et al.
Publicado: (2020) -
The Adenovirus Genome Contributes to the Structural Stability of the Virion
por: Saha, Bratati, et al.
Publicado: (2014) -
Antiviral Effects of Curcumin on Adenovirus Replication
por: Jennings, Morgan R., et al.
Publicado: (2020) -
Identification and characterisation of small molecule inhibitors of feline coronavirus replication
por: McDonagh, Phillip, et al.
Publicado: (2014)